HighTower Advisors’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,143
Closed -$139K 3900
2025
Q2
$139K Sell
33,143
-24,000
-42% -$157K ﹤0.01% 3402
2025
Q1
$98.6K Buy
57,143
+11,429
+25% +$102K ﹤0.01% 3359
2024
Q4
$177K Buy
45,714
+13,714
+43% +$120K ﹤0.01% 3235
2024
Q3
$116K Buy
32,000
+10,286
+47% +$107K ﹤0.01% 3281
2024
Q2
$158K Sell
21,714
-8,686
-29% -$72.6K ﹤0.01% 3094
2024
Q1
$59.1K Buy
+30,400
New +$264K ﹤0.01% 3234
2023
Q2
Sell
-3,429
Closed -$13.1K 3509
2023
Q1
$13.1K Buy
+3,429
New +$28.2K ﹤0.01% 3182

Other funds holding ENVX

HighTower Advisors's ENVX Position: Q1 2026 in Review

HighTower Advisors reduced its Enovix (ENVX) stake by 85% in Q1 2026, selling an estimated $2.14M and leaving 61,947 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #3113.

HighTower Advisors first reported a position in ENVX in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.66M in Q3 2025. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • HighTower Advisors held 61,947 shares of Enovix worth $321K as of Q1 2026.
  • HighTower Advisors sold 341,807 Enovix shares in Q1 2026, an estimated $2.14M.
  • Enovix made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3113 holding.
  • HighTower Advisors first reported a position in Enovix in Q3 2021 and has held it in 19 quarters since.
  • HighTower Advisors's Enovix position peaked at $4.66M in Q3 2025.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.